Evidence map›Paper›PMID 34760326›Full record

ArticleCase reports in pediatrics2021

Multiple Organ Failure Associated with SARS-CoV-2 Infection in a Child with Down Syndrome: Is Trisomy 21 Associated with an Unfavourable Clinical Course?

Perla Idalia Vazquez-Hernández, Alan Cárdenas-Conejo, Manuel Alejandro Catalán-Ruiz, Karla Navar-Gallegos, Emilio Zenteno-Salazar, Jose Rafael-Parra-Bravo, Ranferi Aragon-Nogales, Maribel Ibarra-Sarlat, Juan Carlos Núñez-Enríquez

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. COVID-19 in patients with Down syndrome: A systematic review.Immunity, inflammation and disease · 2024
    Pooled it
  2. [Risk factors in the origin of Down syndrome].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Perla Idalia Vazquez-HernándezPediatric Intensive Unit, National Medical Center "Siglo XXI", Mexican Institute of Social Security, Mexico City 06720, Mexico.
Alan Cárdenas-ConejoDepartment of Medical Genetics, National Medical Center "Siglo XXI", Mexican Institute of Social Security, Mexico City 06720, Mexico.
Manuel Alejandro Catalán-RuizPediatric Intensive Unit, National Medical Center "Siglo XXI", Mexican Institute of Social Security, Mexico City 06720, Mexico.
Karla Navar-GallegosPediatric Intensive Unit, National Medical Center "Siglo XXI", Mexican Institute of Social Security, Mexico City 06720, Mexico.
Emilio Zenteno-SalazarFaculty of Medicine, Marist University of Merida, Yucatán 97300, Mexico.
Jose Rafael-Parra-BravoPediatric Cardiology, General Hospital Tlahuac, Minister of Health, Mexico City 13250, Mexico.
Ranferi Aragon-NogalesFaculty of Medicine, Marist University of Merida, Yucatán 97300, Mexico.
Maribel Ibarra-SarlatPediatric Intensive Unit, National Medical Center "Siglo XXI", Mexican Institute of Social Security, Mexico City 06720, Mexico.
Juan Carlos Núñez-EnríquezClinical Epidemiology Medical Research Unit, National Medical Center "Siglo XXI", Mexican Institute of Social Security, Mexico City 06720, Mexico.ORCID https://orcid.org/0000-0002-8070-9727
Mexican Social Security Institute · MXUniversidad Marista de Mérida · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDown syndrome (DS) is one of the most frequent genomic disorders around the globe (∼1:700 births). During the COVID-19 pandemic, it has been recognized that children with DS are patients with a greater risk of presenting SARS-CoV-2 infection-related poor outcomes. Nonetheless, a few cases with DS and SARS-CoV-2 infection have been reported. Our aim is to describe the unfavorable clinical course of a child with DS infected with SARS-CoV-2 virus. CASE: Female, 2 years old, karyotype 47,XX,+21[30], previously diagnosed with a cyanotic congenital heart disease (tricuspid atresia and infundibular pulmonary stenosis, type Ib) who started with diarrhea, developed shortness of breath, and cyanosis and was admitted to the hospital presenting low-oxygen saturation (33%) requiring invasive mechanical ventilation support. The patient tested positive for SARS-CoV-2 infection. During hospitalization, the patient presented hypotension, anuria, retarded capillary filling, and metabolic acidosis; management with vasoactive drugs was needed. Nonetheless, the patient developed respiratory and cardiac failure, acute renal injury (AKIN-III), and septic shock. After 24 days of hospitalization, the patient died.

conclusionsMultiple organ failure observed in the patient presented could be related to the triple gene dose of four interferon receptors (

Identifiers

PMID34760326
PMCPMC8575596
OpenAlexW3209850604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.